Research Papers:

Spatio-temporal regulation of EGFR signaling by the Eps15 homology domain-containing protein 3 (EHD3)

Mohamed Amessou, Abdul Shukkur Ebrahim, Ashok Dilly, Melvin Joseph, Marina Tabolina, Sahiti Chukkapalli, Louay Meroueh, Joseph T. Syed, Allison Liddane, Siera Lanae Lang, Ayad Al-Katib and Mustapha Kandouz _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:79203-79216. https://doi.org/10.18632/oncotarget.13008

Metrics: PDF 977 views  |   HTML 1317 views  |   ?  


Mohamed Amessou1, Abdul Shukkur Ebrahim2, Ashok Dilly1, Melvin Joseph1, Marina Tabolina1, Sahiti Chukkapalli1, Louay Meroueh1, Joseph T. Syed1, Allison Liddane2, Siera Lanae Lang1, Ayad Al-Katib2, Mustapha Kandouz1,3

1Department of Pathology, Wayne State University School of Medicine, Detroit, Michigan, USA

2Lymphoma Research Lab, Wayne State University School of Medicine, Detroit, Michigan, USA

3Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, USA

Correspondence to:

Mustapha Kandouz, email: ag1764@wayne.edu

Keywords: EHD3, EGFR, glioblastoma, signaling

Received: November 15, 2015     Accepted: August 21, 2016     Published: November 01, 2016


The epidermal growth factor (EGF) receptor EGFR is a major receptor tyrosine kinase whose role in gliomagenesis is well established. We have recently identified EHD3 [Eps15 homology (EH) domain-containing protein 3], an endocytic trafficking regulatory protein, as a putative brain tumor suppressor. Here, we investigate the underlying mechanisms, by establishing a novel mechanistic and functional connection between EHD3 and the EGFR signaling pathway. We show that, in response to stimulation with the EGF ligand, EHD3 accelerates the rate of EGFR degradation by dramatically increasing its ubiquitination. As part of this process, EHD3 also regulates EGFR endosomal trafficking by diverting it away from the recycling route into the degradative pathway. Moreover, we found that upon EGF activation, rather than affecting the total MAPK and AKT downstream signaling, EHD3 decreases endosome-based signaling of these two pathways, thus suggesting the contribution of EHD3 in the spatial regulation of EGFR signaling. This function explains the higher sensitivity of EHD3-expressing cells to the growth-inhibitory effects of EGF. In summary, this is the first report supporting a mechanism of EHD3-mediated tumor suppression that involves the attenuation of endosomal signaling of the EGFR oncogene.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 13008